Human Pancreatic Cancer Stem Cells Are Sensitive to Dual Inhibition of IGF-IR and ErbB Receptors

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1249-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

Clinical Cancer Research
Cancer ResearchOncology
2015English

Dual Inhibition of BMP and WNT Signals Promotes Pancreatic Differentiation From Human Pluripotent Stem Cells

Stem Cells International
Cell BiologyMolecular Biology
2019English

Human Microvascular Endothelial Cells Are Sensitive to IGF-I but Resistant to Insulin at the Receptor Level

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2008English

Dual Inhibition of IGF-IR and ALK as an Effective Strategy to Eradicate NPM-ALK+ T-Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Cancer Stem Cells in Pancreatic Cancer

Cancers
Cancer ResearchOncology
2010English

Targeting Pancreatic Cancer Stem Cells

Journal of Cancer Sciences
2015English

Lapatinib, a Dual Inhibitor of ErbB-1/-2 Receptors, Enhances Effects of Combination Chemotherapy in Bladder Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2009English

Pancreatic Cancer Spheres Are More Than Just Aggregates of Stem Marker-Positive Cells

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2010English

Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy